机构：[1]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Beijing, Peoples R China[2]First Hosp Jilin Univ, Changchun, Jilin, Peoples R China[3]Beijing Friendship Hosp, Beijing, Peoples R China首都医科大学附属北京友谊医院[4]Zhongshan Hosp, Shanghai, Peoples R China[5]Tianjin Chest Hosp, Tianjin, Peoples R China[6]Xuanwu Hosp, Beijing, Peoples R China首都医科大学宣武医院[7]Guangdong Gen Hosp, Foshan, Peoples R China广东省人民医院[8]Sixth Peoples Hosp, Shanghai, Peoples R China
出处：
ISSN：
摘要：
BACKGROUND The prospective BRIC study revealed the incidence of
post discharge bleeding (PDB) (post)cardiovascular events in Chinese
acute coronary syndromes (ACS) patients with real-world. To evaluate
the optimal dual antiplatelet therapy (DAPT) in ACS patients with high
bleeding risk (HBR), we performed an explorative analysis of the BRIC
study.
METHODS A total of 7531 ACS patients treated with PCI and followed
up for 1-year in 30 Chinese hospitals from May 2014 to January 2016
and October 2017 to April 2019 were enrolled, of which 1361 (18%) were
with HBR.
第一作者机构：[1]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Li Dandan,Zheng Yang,Chen Hui,et al.The Antiplatelet Therapy in Chinese Post Stenting Patients With High Bleeding Risk Patients With Acute Coronary Syndrome: Insights From BRIC Study[J].JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY.2025,85(15):
APA：
Li, Dandan,Zheng, Yang,Chen, Hui,Qian, Juying,Qin, Qin...&Chen, Yundai.(2025).The Antiplatelet Therapy in Chinese Post Stenting Patients With High Bleeding Risk Patients With Acute Coronary Syndrome: Insights From BRIC Study.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,85,(15)
MLA：
Li, Dandan,et al."The Antiplatelet Therapy in Chinese Post Stenting Patients With High Bleeding Risk Patients With Acute Coronary Syndrome: Insights From BRIC Study".JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 85..15(2025)
医学